In a study, Sy et al. [110] reported that the alteration of tau from a soluble form to an insoluble form in AD transgenic mice was linked with the inflammatory response and over-activity of glycogen synthase kinase-3 (GSK-3). This evidence concerns the gene MAPT and Alzheimer disease.